Clinical Trial Update: Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure [EARLY_Phase 1]

View source ↗

Summary

Pilot Phase 1 study evaluating daratumumab with CyBorD (cyclophosphamide, bortezomib, dexamethasone) in newly diagnosed multiple myeloma patients with renal imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Renal Failure

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)

Snippet

Sponsor: Augusta University | Conditions: Multiple Myeloma, Renal Failure | EARLY_Phase 1 | Status: RECRUITING